English
中文版| Structure | Cat.No. | Chemical Name | CAS No. |
|---|---|---|---|
 |
KY151002 | N-formyl-l-leucine | 6113-61-7 |
 |
KY151003 | Acetamide, n-(3-acetyl-2-hydroxyphenyl)- | 103205-33-0 |
![(1R,2S)-2-[(Phenylmethoxy)methyl]-3-cyclopenten-1-ol](https://qncdn.chemcd.cn/keying/structure/KY151004.png) |
KY151004 | (1R,2S)-2-[(Phenylmethoxy)methyl]-3-cyclopenten-1-ol | 188399-48-6 |
![(1S,2R,3S,5R)-3-(Phenylmethoxy)-2-[(phenylmethoxy)methyl]-6-oxabicyclo[3.1.0]hexane](https://qncdn.chemcd.cn/keying/structure/KY151005.png) |
KY151005 | (1S,2R,3S,5R)-3-(Phenylmethoxy)-2-[(phenylmethoxy)methyl]-6-oxabicyclo[3.1.0]hexane | 110567-22-1 |
 |
KY150970 | Daclatasvir Intermediates Ⅱ | 1007882-23-6 |
 |
KY150971 | 1,1’-(1,1’-Biphenyl)-4,4’-diylbis(2-bromoethan-1-one | 4072-67-7 |
 |
KY150972 | (S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-4-morpholinobutanoic acid | 1004316-92-0 |
 |
KY150973 | Thiazol-5-ylmethyl (2r,5r)-5-amino-1,6-diphenylhexan-2-ylcarbamate hydrochloride | 1247119-33-0 |
![(alphaS)-alpha-[[[Methyl[[2-(1-Methylethyl)-4-thiazolyl]Methyl]aMino]carbonyl]aMino]-4-Morpholinebutanoic acid Methyl ester](https://qncdn.chemcd.cn/keying/structure/KY150974.png) |
KY150974 | (alphaS)-alpha-[[[Methyl[[2-(1-Methylethyl)-4-thiazolyl]Methyl]aMino]carbonyl]aMino]-4-Morpholinebutanoic acid Methyl ester | 1004316-91-9 |